Announcements Trials
Browse Landscape

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Leukemia 1HR+HER2- Advanced Breast Cancer 1Advanced Gastric Cancer 1

Interventions

Gene Expression Profiling 33Flow Cytometry 30Microarray Analysis 22Polymerase Chain Reaction 21Reverse Transcriptase Polymerase Chain Reaction 13Amplified Fragment Length Polymorphism Analysis 11Cytogenetic Analysis 10Surveys and Questionnaires 9DNA Methylation 9Blotting, Western 9Psychiatric Rehabilitation 8Immunologic Techniques 8Base Sequence 8In Situ Hybridization, Fluorescence 6Blood Specimen Collection 6Interviews as Topic 5Therapeutics 3Immunoenzyme Techniques 3Imatinib Mesylate 3Gene Rearrangement 3Watchful Waiting 2Pharmacogenomic Testing 2Mental Status and Dementia Tests 2Mass Spectrometry 2Genetic Testing 2Data Collection 2Dasatinib 2Counseling 2Cell Culture Techniques 2Blotting, Southern 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Leukemia × Drug Therapy, Combination × Clear all
NCT06649422 2024-10-18

Reduced-Dose Chemo Followed by 14 Days of Blinatumomab for Newly Diagnosed Adult B-ALL Patients: a Multicenter Study

Shandong University

Not yet recruiting
36 enrolled
Other hematologic neoplasm

Leukemia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡